0001725160-22-000180.txt : 20221003
0001725160-22-000180.hdr.sgml : 20221003
20221003184244
ACCESSION NUMBER: 0001725160-22-000180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221003
FILED AS OF DATE: 20221003
DATE AS OF CHANGE: 20221003
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Epperly Melissa B,
CENTRAL INDEX KEY: 0001807359
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39263
FILM NUMBER: 221289036
MAIL ADDRESS:
STREET 1: C/O ZENTALIS PHARMACEUTICALS, INC.
STREET 2: 530 SEVENTH AVENUE, SUITE 2201
CITY: NEW YORK
STATE: NY
ZIP: 10018
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Zentalis Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001725160
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 823607803
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1359 BROADWAY, SUITE 1710
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: (212) 433-3791
MAIL ADDRESS:
STREET 1: 1359 BROADWAY, SUITE 1710
CITY: NEW YORK
STATE: NY
ZIP: 10018
FORMER COMPANY:
FORMER CONFORMED NAME: Zentalis Pharmaceuticals, LLC
DATE OF NAME CHANGE: 20200107
FORMER COMPANY:
FORMER CONFORMED NAME: Zeno Pharma, LLC
DATE OF NAME CHANGE: 20171212
4
1
wf-form4_166483690075305.xml
FORM 4
X0306
4
2022-10-03
0
0001725160
Zentalis Pharmaceuticals, Inc.
ZNTL
0001807359
Epperly Melissa B,
C/O ZENTALIS PHARMACEUTICALS, INC.
1359 BROADWAY, SUITE 1710
NEW YORK
NY
10018
0
1
0
0
Chief Financial Officer
Common Stock
2022-10-03
4
A
0
50000
0
A
297543
D
Represents restricted stock units ("RSUs") granted by the Issuer under the 2020 Incentive Award Plan, as amended. The RSUs will vest over two years: 1/3 of the RSUs will vest on the first anniversary of the date of grant, and the remaining 2/3 of the RSUs will vest on the second anniversary of the date of grant.
Includes 129 shares acquired under the Zentalis Pharmaceuticals, Inc. 2020 Employee Stock Purchase Plan on September 30, 2022.
By: /s/ Melissa B. Epperly
2022-10-03